金吾财讯 | 有报道引述知情人士称，复星医药(02196)正考虑将其附属公司复宏汉霖(02696)私有化，并正就潜在的私有化要约与一家顾问公司进行合作；其他投资者也可能参与交易。报道称，磋商正在进行，但不一定会促成交易。
复宏汉霖自5月23日起停牌。
【港股通】据报复星医药(02196)拟将附属复宏汉霖(02696)私有化
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.